Shandong Cancer Hospital And Institute

This study looks at whether adding a precise type of radiation (SBRT) to standard maintenance therapy can help people with advanced pancreatic cancer live longer. It involves 24 adults whose cancer has not spread further after initial chemotherapy. The goal is to see if the combi…

This study is for people with endometrial cancer that has come back or spread to a few other spots. It tests a new drug called cadonilimab given together with chemotherapy and radiation. The goal is to see if this combination can shrink tumors and help people live longer without …

This study tests a new drug called ivonescimab, combined with targeted radiation and chemotherapy, for people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this combination is safe and can help control the disease longer. About 3…

This study is for people with advanced liver cancer (BCLC stage C) that has spread to blood vessels or other organs. It compares standard drug therapy alone versus drug therapy plus a precise type of radiation called SBRT. The goal is to see if adding radiation helps people live …

This study tests whether adding the antifungal drug posaconazole to standard immunotherapy and chemotherapy can help more people with triple-negative breast cancer achieve a complete response before surgery. About 72 women with early-stage, high-risk disease will participate. The…

This study tests whether adding radiotherapy to a drug combination (fruquintinib and sintilimab) can help control colorectal cancer that has spread to the liver and hasn't responded to two prior treatments. About 62 adults with a specific cancer subtype (MSS/pMMR) will be randoml…

This study compares a new type of radiation therapy (SFRT) to standard radiation for people with large soft tissue sarcomas (tumors at least 5 cm). About 106 participants will be randomly assigned to one of the two treatments. The goal is to see if SFRT can shrink tumors better a…

This study tests a new treatment plan for people with advanced liver cancer that has spread to the main blood vessel or to a few other spots in the body. The treatment combines chemotherapy directly into the liver, two immunotherapy drugs, a targeted therapy, and precise radiatio…

This phase 3 trial tests whether a newer oral chemotherapy drug, TAS-102, works better than the standard drug capecitabine when given with radiation before surgery for locally advanced rectal cancer. About 210 adults aged 18-75 with stage II or III rectal cancer will take part. T…

This study tests whether adding the targeted drug nimotuzumab to standard radiation therapy helps control advanced head and neck cancer better than radiation alone. It is for patients who cannot take platinum-based chemotherapy. About 335 adults with stage III-IVB head and neck s…

This study tests whether adding the immunotherapy drug sintilimab to standard chemotherapy and radiation can help people with pancreatic cancer that cannot be removed by surgery. The trial will enroll 25 adults who have not had prior treatment for their cancer. Researchers will m…

This study looks at colorectal cancer patients whose disease is under control (no evidence of cancer) but later develop a few new lung spots. Instead of starting chemotherapy right away, doctors will treat those spots with surgery or radiation and then watch closely. The goal is …

This study tests a new nano-formulation of megestrol acetate in 56 patients with advanced pancreatic cancer who suffer from anorexia-cachexia syndrome, a condition causing severe appetite loss and weight loss. The goal is to see if the drug can help patients gain weight, improve …

This study looks at 300 people with HER2-positive breast cancer that hasn't spread. It checks if having very high HER2 levels (called ultra-high) changes how well a two-drug treatment works. The goal is to see if these patients have different survival rates without cancer coming …